Chronic hepatitis C (CHC) is a leading cause of hepatic fibrosis and cirrhosis. The level of
fibrosis is traditionally established by histology, and prognosis is estimated using fibrosis …

Abstract Background and Aim Liver stiffness (LS), measured by transient elastography, has
been validated as a non‐invasive surrogate for liver fibrosis. Methods We investigated the …

Background Transient elastography (TE), a non-invasive tool that measures liver stiffness,
has been evaluated in meta-analyses for effectiveness in assessing liver fibrosis in …

Background Our objective was to study the prognostic value of liver stiffness (LS) in HIV-
infected patients with chronic hepatitis C (CHC). Methods We analyzed HIV-infected patients …

Background/Aims Liver stiffness (LS) measurement by means of transient elastography (TE)
is accurate to predict fibrosis stage. The effect of antiviral treatment and virologic response …

Liver fibrosis is the main predictor of the progression of chronic hepatitis C, and its
assessment by liver biopsy (LB) can help determine therapy. However, biopsy is an invasive …

Background & Aims. e current study aimed to establish the liver stiffness (LS) cut-off values
and their performance in the prediction of the brosis stage in chronic hepatitis C (CHC) …

Accurate evaluation of the degree of liver fibrosis in patients with chronic liver diseases
(CLD) is crucial, as liver fibrosis is important in determining the prognosis of liver diseases …

Transient elastography (TE) is a new non-invasive tool for assessing liver stiffness, which is
correlated with the histologic stage of liver fibrosis. Many studies have reported a good …

Abstract Background & Aims Transient elastography based on liver stiffness measurement is
a non‐invasive method to assess hepatic fibrosis. However, interobserver variability has led …